Creatine therapy for Huntington's disease: clinical and MRS findings in a 1-year pilot study.
about
Therapeutic interventions for disease progression in Huntington's diseaseTargeting cellular energy production in neurological disorders.A phase I, pharmacokinetic, dosage escalation study of creatine monohydrate in subjects with amyotrophic lateral sclerosisExploratory 7-Tesla magnetic resonance spectroscopy in Huntington's disease provides in vivo evidence for impaired energy metabolism.Cardiac dysfunction in the R6/2 mouse model of Huntington's diseaseEmerging chemotherapeutic strategies for Huntington's disease.The application of NMR-based metabonomics in neurological disorders.Huntington's disease: pathological mechanisms and therapeutic strategies.Therapeutic perspectives for the treatment of Huntington's disease: treating the whole bodyHuntington's disease: progress and potential in the field.Evidence of oxidant damage in Huntington's disease: translational strategies using antioxidants.Exploring the therapeutic role of creatine supplementation.Emerging drug therapies in Huntington's disease.Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines.Creatine in mouse models of neurodegeneration and aging.Pharmacologic approaches to the treatment of Huntington's disease.In sickness and in health: the widespread application of creatine supplementation.The CREST-E study of creatine for Huntington disease: A randomized controlled trial.Advancing pharmacotherapy for treating Huntington's disease: a review of the existing literature.Beyond muscles: The untapped potential of creatine.A longitudinal study of magnetic resonance spectroscopy Huntington's disease biomarkers.Nucleic Acid-Based Therapy Approaches for Huntington's Disease(1)H NMR brain metabonomics of scrapie exposed sheep.Effects of a Sativex-Like Combination of Phytocannabinoids on Disease Progression in R6/2 Mice, an Experimental Model of Huntington's Disease.Creatine supplementation lowers brain glutamate levels in Huntington's disease.No effects of lifelong creatine supplementation on sarcopenia in senescence-accelerated mice (SAMP8).Manganese and the Insulin-IGF Signaling Network in Huntington's Disease and Other Neurodegenerative Disorders.Exocytotic release of creatine in rat brain.
P2860
Q24239973-6491648A-D0F0-4D61-A806-C79C2ADE93D2Q34266266-D3637F99-9236-4F32-981D-FAFAAC470BDAQ34610044-270E5861-2A98-475A-8D23-A6FAA2F37F7AQ35577423-61838CDE-628A-4CAB-9527-92494D468AF6Q35745626-30128336-9234-4C5A-93C4-2D0C7DEBB30DQ36150628-3D8298FD-F974-4407-AA0F-B3DBFD612F43Q36525175-CC427279-A418-4652-BBE9-604A76E33F83Q36822322-EE5DB109-CBA4-4071-A8C8-B39C2176FE79Q36999830-CB24886E-382A-419A-81CA-D471BC948839Q37016096-7991C0F9-4782-4870-B03F-B2E5AAD29E0BQ37348546-8967D7C8-E619-4C41-A41B-694341E7A400Q37404612-A2E10F7C-8958-4349-B432-58A0ADAC1E07Q37488273-EDCC49DB-3099-4DD5-94B6-5C32505C0D33Q37580731-4B96A552-86B1-408A-9683-F2AF3D6AE0D0Q37851389-911F8E4B-68F3-4B34-9B62-0A0A938979D0Q37945478-6E8EA4A0-ED91-4719-912B-B33D4CB44609Q37958749-745F74CF-A348-46DD-AA69-C065027833F7Q38374092-CF681A85-C0C7-4707-B7E3-93CDA335C08AQ38624994-9240D2A0-0B5E-45AE-AF7A-FDB6E5846831Q38700215-5B44D339-B5F1-4AFC-930C-3C33B93F567CQ39037892-A4BB8E86-5175-471B-BBE4-252BB786D3DDQ40582623-12D8251C-F822-4002-ACB3-23B5C9B2D1DFQ40955735-7ADE5030-C623-4BAA-BE86-008CFBB92CBFQ42289980-7BDF1B8A-04C6-4D51-A4EC-E0A833A97FEDQ45239341-59C3548A-1256-4F27-9E5E-B88C1DB17F5AQ45280328-09C6E860-A08B-4118-A9ED-A3DCB4FD28C6Q46309597-7365BB7C-D842-44DF-B5A6-FACF004BA93EQ48529509-7557A8A9-9EF3-4982-8D40-374C0F0F5DD3
P2860
Creatine therapy for Huntington's disease: clinical and MRS findings in a 1-year pilot study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Creatine therapy for Huntingto ...... dings in a 1-year pilot study.
@en
Creatine therapy for Huntingto ...... dings in a 1-year pilot study.
@nl
type
label
Creatine therapy for Huntingto ...... dings in a 1-year pilot study.
@en
Creatine therapy for Huntingto ...... dings in a 1-year pilot study.
@nl
prefLabel
Creatine therapy for Huntingto ...... dings in a 1-year pilot study.
@en
Creatine therapy for Huntingto ...... dings in a 1-year pilot study.
@nl
P2093
P1433
P1476
Creatine therapy for Huntingto ...... ndings in a 1-year pilot study
@en
P2093
A H V Schapira
A M Blamire
B Rajagopalan
D N Manners
P304
P356
10.1212/01.WNL.0000070186.97463.A7
P407
P577
2003-07-01T00:00:00Z